SCHEMBL1076548

SCHEMBL1076548

Cc1csc(NC(=O)c2cccc3ccc(-c4cccc(N5CCOCC5)c4)nc23)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLQ O75417 1/20 0.47
▸ PHGDH O43175 1/20 0.47
▸ NPC1 O15118 6/20 0.45
▸ RAB9A P51151 6/20 0.45
▸ LMNA P02545 4/20 0.44
▸ HTT P42858 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ POLB P06746 2/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ HPGD P15428 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ RCE1 Q9Y256 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ ATR Q13535 1/20 0.43
▸ PKM P14618 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1032599 0.86 POLQ (0.50) POLQPHGDHNPC1RAB9ALMNA
SCHEMBL1204609 0.86 POLQ (0.53) POLQNPC1RAB9AALDH1A1L3MBTL1
SCHEMBL1032671 0.86 POLQ (0.47) POLQPHGDHNPC1RAB9AMEN1
SCHEMBL1035704 0.85 POLQ (0.51) POLQNPC1RAB9AALDH1A1HPGD
SCHEMBL1076488 0.85 POLQ (0.44) POLQPHGDHNPC1RAB9AMAPT
SCHEMBL1035037 0.85 LMNA (0.53) POLQPHGDHNPC1RAB9ALMNA
SCHEMBL1075258 0.85 RAB9A (0.47) POLQNPC1RAB9AMAPTALDH1A1
SCHEMBL1034084 0.84 ATR (0.45) POLQNPC1RAB9AMAPTATR
SCHEMBL1035334 0.83 POLQ (0.44) POLQPHGDHNPC1RAB9AMAPT
SCHEMBL1031618 0.83 LRRK2 (0.60) NPC1RAB9ALMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2273992-B1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC (US) 2016-05-25 — — EP disclosed
EP-2273992-B1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC (US) 2016-05-25 — — EP disclosed
US-20110046110-A1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2011-02-24 — — US disclosed
US-20110046110-A1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2011-02-24 — — US disclosed
US-20110046110-A1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2011-02-24 — — US disclosed
EP-2273992-A1 QUENOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS Sirtris Pharmaceuticals, Inc. (US) 2011-01-19 — — EP disclosed
WO-2009134973-A1 QUENOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS SIRTRIS PHARMACEUTICALS, INC. (US) 2009-11-05 — — WO disclosed
WO-2009134973-A1 QUENOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS SIRTRIS PHARMACEUTICALS, INC. (US) 2009-11-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046110-A1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS SIRT3, SIRT1, SIRT2 POLQ 1064/4885PHGDH 1559/4885NPC1 3386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback